Burra, P., Zanetto, A. & Germani, G. Sex bias in clinical trials in gastroenterology and hepatology. Nat. Rev. Gastroenterol. Hepatol. 19, 413–414 (2022).
Article PubMed PubMed Central Google Scholar
Mauvais-Jarvis, F. et al. Sex and gender: modifiers of health, disease, and medicine. Lancet 396, 565–582 (2020).
Article PubMed PubMed Central Google Scholar
Bizzaro, D. et al. Influence of sex in alcohol-related liver disease: pre-clinical and clinical settings. United Eur. Gastroenterol. J. 11, 218–227 (2023).
Burra, P. et al. Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int. 41, 1713–1733 (2021).
Goodman, W. A., Erkkila, I. P. & Pizarro, T. T. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 740–754 (2020).
Article PubMed PubMed Central Google Scholar
Guarino, M. et al. Sarcopenia in chronic advanced liver diseases: a sex-oriented analysis of the literature. Dig. Liver Dis. 54, 997–1006 (2022).
Toniutto, P. et al. Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review. Hepatology 79, 1141–1157 (2023).
Zanetto, A. et al. Vascular liver diseases: a sex-oriented analysis of the literature. Dig. Liver Dis. 55, 178–186 (2023).
Lefebvre, P. & Staels, B. Hepatic sexual dimorphism – implications for non-alcoholic fatty liver disease. Nat. Rev. Endocrinol. 17, 662–670 (2021).
Knolle, P. A. & Thimme, R. Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology 146, 1193–1207 (2014).
Article CAS PubMed Google Scholar
Jenne, C. N. & Kubes, P. Immune surveillance by the liver. Nat. Immunol. 14, 996–1006 (2013).
Article CAS PubMed Google Scholar
Doherty, D. G. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J. Autoimmun. 66, 60–75 (2016).
Article CAS PubMed Google Scholar
Crispe, I. N. The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147–163 (2009).
Article CAS PubMed Google Scholar
Gao, B., Jeong, W. I. & Tian, Z. Liver: an organ with predominant innate immunity. Hepatology 47, 729–736 (2008).
Article CAS PubMed Google Scholar
Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43, S54–S62 (2006).
Article CAS PubMed Google Scholar
Tiegs, G. & Lohse, A. W. Immune tolerance: what is unique about the liver. J. Autoimmun. 34, 1–6 (2010).
Article CAS PubMed Google Scholar
Costa, D. et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J. Hepatol. 74, 819–828 (2021).
Article CAS PubMed Google Scholar
Liberal, R., Grant, C. R., Mieli-Vergani, G. & Vergani, D. Autoimmune hepatitis: a comprehensive review. J. Autoimmun. 41, 126–139 (2013).
Article CAS PubMed Google Scholar
Shin, E. C., Sung, P. S. & Park, S. H. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat. Rev. Immunol. 16, 509–523 (2016).
Article CAS PubMed Google Scholar
Zanetto, A. et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. J. Hepatol. 78, 301–311 (2023).
Article CAS PubMed Google Scholar
Zanetto, A. et al. Toward a more precise prognostic stratification in acute decompensation of cirrhosis: the Padua model 2.0. United Eur. Gastroenterol. J. 11, 815–824 (2023).
Zhang, S., Lu, S. & Li, Z. Extrahepatic factors in hepatic immune regulation. Front. Immunol. 13, 941721 (2022).
Article CAS PubMed PubMed Central Google Scholar
Meijnikman, A. S. et al. Microbiome-derived ethanol in nonalcoholic fatty liver disease. Nat. Med. 28, 2100–2106 (2022).
Article CAS PubMed Google Scholar
Schwabe, R. F. & Greten, T. F. Gut microbiome in HCC – mechanisms, diagnosis and therapy. J. Hepatol. 72, 230–238 (2020).
Article CAS PubMed Google Scholar
Yin, Y. et al. Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis. J. Hepatol. 78, 820–835 (2023).
Article CAS PubMed Google Scholar
Karlsen, T. H. et al. The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality. Lancet 403, 1522–1524 (2024).
Karlsen, T. H. et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 399, 61–116 (2022).
Heidari, S. et al. WHO’s adoption of SAGER guidelines and GATHER: setting standards for better science with sex and gender in mind. Lancet 403, 226–228 (2024).
Heymann, F. & Tacke, F. Immunology in the liver – from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol. 13, 88–110 (2016).
Article CAS PubMed Google Scholar
Kasarinaite, A., Sinton, M., Saunders, P. T. K. & Hay, D. C. The influence of sex hormones in liver function and disease. Cells 12, 1604 (2023).
Article CAS PubMed PubMed Central Google Scholar
Della Torre, S. & Maggi, A. Sex differences: a resultant of an evolutionary pressure. Cell Metab. 25, 499–505 (2017).
Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542–1556 (2023).
Article CAS PubMed Google Scholar
Catala-Senent, J. F. et al. Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies. Biol. Sex. Differ. 12, 29 (2021).
留言 (0)